Yuanlong Hu

Dr. Yuanlong Hu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2023 in Frontiers in Psychiatry
Verified
Journal Article
Open access
XLXintong Li
Xintong Li
JHJiaming Huan
Jiaming Huan
LLLin Lin
Lin Lin
YHYuanlong Hu
Yuanlong Hu
Background/Aim: Depression has become a multiple disease worldwide, and is closely related to the systemic inflammatory response.Methods: Based on the data of the National Health and Nutrition Examination Survey (NHANES), this study included 2,514 depressive and 26,487 non-depressive adults. The systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) were used to quantify systemic inflammation. The multivariate logistic regression and inverse probability weighting methods were used to analyze the effect size of SII and SIRI on the risk of depression.Results: After adjusting for all confounders, the above associations of SII and SIRI with depression risk remained significant (SII, OR = 1.02, 95% CI = 1.01 to 1.02, p = 0.001; SIRI, OR = 1.06, 95% CI = 1.01 to 1.10, p = 0.016). Each 100-unit increase in SII was associated with a 2% increase in the risk of depression, while each one-unit increase in SIRI was associated with a 6% increase in the risk of depression.Conclusion: Systemic inflammatory biomarkers (SII and SIRI) significantly affected the risk of depression. SII or SIRI can serve as a biomarker of anti-inflammation treatment for depression.

30 May 2024 in Current Atherosclerosis Reports
Verified
Journal Article
Closed access
PDF file
XGXiuya Guan
Xiuya Guan
YHYuanlong Hu
Yuanlong Hu
JHJiaqi Hao
Jiaqi Hao
MLMengkai Lu
Mengkai Lu
ZZZhiyuan Zhang
Zhiyuan Zhang
CLChao Li
Chao Li

24 March 2026 in Experimental Gerontology
Verified
Journal Article
Open access
RSRui Sun
Rui Sun
XLXintong Li
Xintong Li
XCXinhai Cui
Xinhai Cui
XGXiuya Guan
Xiuya Guan
ZZZhiyuan Zhang
Zhiyuan Zhang
CLChao Li
Chao Li
Cardiovascular-kidney-metabolic syndrome (CKM) is closely associated with obesity, diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD). Although the dietary inflammatory index (DII) reflects the inflammatory potential of diet, the relationship between CKM and DII, as well as the potential mediators, remains unclear. This prospective cohort study included adults with complete dietary data from the National Health and Nutrition Examination Survey (NHANES) 2003-2018. DII was ascertained using the 24-hour recall method. Cox models and cubic spline analyses assessed mortality risk, while the mediating role of insulin resistance-related indicators was further investigated by causal mediation analysis. As of December 31, 2019, a total of 2,505 (13.4%) all-cause deaths and 777 (4.1%) cardiovascular deaths were documented in 18,746 adults over a median follow-up of approximately 8 years. Highest DII tertile showed increased all-cause mortality (HR = 1.24, 95%CI:1.11-1.37) and cardiovascular mortality (HR = 1.22, 95%CI:1.01-1.48) versus lowest tertile. RCS analysis showed that mortality risk increased linearly with increasing DII (all-cause mortality: P for overall: <0.001; cardiovascular mortality: P for overall: <0.135). The time-dependent curves show the long-term predictive performance of DII. In addition, TyG-WC and TyG-WHtR mediated 4.69% and 4.18% of all-cause mortality and 13.13% and 13.96% of cardiovascular mortality (both P < 0.05) in DII and CKM patients, respectively. Elevated DII was strongly associated with an elevated risk of death in patients with CKM. In addition, the TyG index and its combined indicator of abdominal obesity partially mediated the association between DII and mortality risk in CKM.